PROGNOSTIC STAGE IB BREAST CANCER AJCC V8
Clinical trials for PROGNOSTIC STAGE IB BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PROGNOSTIC STAGE IB BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for PROGNOSTIC STAGE IB BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo for aggressive breast cancer hits roadblock: trial stopped early
Disease control TerminatedThis study tested two drugs, nab-paclitaxel and alpelisib, given before surgery to people with a fast-growing type of breast cancer (triple-negative) that didn't respond to standard chemo. The goal was to shrink tumors before surgery. Only 6 people took part before the study was …
Matched conditions: PROGNOSTIC STAGE IB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New program aims to boost Well-Being in young black breast cancer survivors
Symptom relief TerminatedThis study tested a program to improve quality of life for young African American women who finished treatment for early or late-stage breast cancer. About 27 women took part in either the program or a control group. The goal was to see if the program helped with physical, emotio…
Matched conditions: PROGNOSTIC STAGE IB BREAST CANCER AJCC V8
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 16, 2026 12:54 UTC
-
Phone support program aims to ease daily struggles for young black breast cancer patients
Symptom relief TerminatedThis study tested a program called Y-AMBIENT, designed to improve quality of life for young African American women (ages 18-44) with stage I-III breast cancer who are undergoing chemotherapy or radiation. The program included phone sessions, written materials, and videos over fou…
Matched conditions: PROGNOSTIC STAGE IB BREAST CANCER AJCC V8
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 15, 2026 19:07 UTC
-
Can a gut pill tame Chemo's stomach woes?
Symptom relief TerminatedThis study looked at whether rifaximin, a gut-focused antibiotic, could reduce stomach problems like pain, bloating, and diarrhea caused by pertuzumab-based chemotherapy in people with early-stage HER2-positive breast cancer. The goal was to help patients complete their cancer tr…
Matched conditions: PROGNOSTIC STAGE IB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC